Database & Systems Committee
| Catherine Beaucé
(Chair) |
Sanofi Aventis |
France |
| Silke Behrendt |
Boehringer Ingelheim |
Germany |
| Christina Fogh Nielsen |
Novo Nordisk |
Denmark |
| Petra Mannechez |
Bayer Schering
Healthcare |
Germany |
| Jacky Gossage |
Glaxosmithkline |
UK |
| Rebecca Leyland |
AstraZeneca |
UK |
| Axel Rocholl |
F.Hoffmann-La Roche |
Switzerland |
| Paw Trebbien |
Nycomed |
Denmark |
| Martina Pinterova |
UCB |
Belgium |
| Alan Harrison |
IMS |
UK |
| Bridget Wiseman |
IMS |
UK |
| Sarah Matthews |
IMS |
UK |
Objectives
Ensure databases & systems provide the best suitable
platform to do international secondary market research through
partnership with the major global providers.
Activities
1. Regular meetings with core providers IMS HEALTH & CEGEDIM
STRATEGIC DATA to discuss their databases & systems offerings
(quality, reliability & service associated) and main
development pathways (meet business data requirements, address
changing market dynamics or make the best use of latest
technologies). They represent a key communication channel between
global secondary data providers and international secondary market
research functions from pharmaco’s.
2. Share experiences & best practice in
international secondary pharmaceutical market research area using
any type of data : sales, medical or Promotional.
3. Identify current unmet needs of
international pharmaceutical market research and share them with
Syndicated Data Committee to cooperate on provider research.
The Committee consists of pharmaceutical international market
research representatives and IMS & CSD representatives. Project
teams may be formed to address specific needs and other providers
may be invited to participate whenever appropriate. The Committee
always welcomes new members from pharmaceutical industry to enlarge
its knowledge & experience sharing.